相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparison of sequence changes of precore and core promoter regions in HBeAg-positive chronic hepatitis B patients with and without HBeAg clearance in lamivudine therapy
CH Chen et al.
JOURNAL OF HEPATOLOGY (2006)
Factors related to post-treatment relapse in chronic hepatitis B patients who lost HBeAg after lamivudine therapy
KS Byun et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update
YF Liaw et al.
LIVER INTERNATIONAL (2005)
Long-term results of lamivudine monotherapy in Korean patients with HBeAg-positive chronic hepatitis B: Response and relapse rates, and factors related to durability of HBeAg seroconversion
SK Yoon et al.
INTERVIROLOGY (2005)
Comparison of clinical outcome between patients continuing and discontinuing lamivudine therapy after biochemical breakthrough of YMDD mutants
CH Chen et al.
JOURNAL OF HEPATOLOGY (2004)
Determinants for sustained HBeAg response to lamivudine therapy
RN Chien et al.
HEPATOLOGY (2003)
Long-term additional lamivudine therapy enhances durability of lamivudine-induced HBeAg loss: a prospective study
SH Ryu et al.
JOURNAL OF HEPATOLOGY (2003)
Durability of serologic response after lamivudine treatment of chronic hepatitis B
JL Dienstag et al.
HEPATOLOGY (2003)
Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B:: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase
AB van Nunen et al.
GUT (2003)
Correlation between ultrasonographic and pathologic diagnoses of hepatitis B and C virus-related cirrhosis
CH Hung et al.
JOURNAL OF GASTROENTEROLOGY (2003)
Durability of lamivudine-induced HBeAg seroconversion for chronic hepatitis B patients with acute exacerbation
CM Lee et al.
JOURNAL OF HEPATOLOGY (2002)
Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B
YS Hsu et al.
HEPATOLOGY (2002)
Effect of virological response on post-treatment durability of lamivudine-induced HBeAg seroconversion
KM Lee et al.
JOURNAL OF VIRAL HEPATITIS (2002)
Management of hepatitis B: 2000 - Summary of a workshop
AS Lok et al.
GASTROENTEROLOGY (2001)
Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapy
NWY Leung et al.
HEPATOLOGY (2001)
Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy
C Boni et al.
HEPATOLOGY (2001)
Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea
BC Song et al.
HEPATOLOGY (2000)
Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B
YF Liaw et al.
GASTROENTEROLOGY (2000)
分享论文
